Medical Specialists: DOA or Alive and Kicking?
Executive SummaryIn the early 1990s, many physician specialists feared that managed care would put them out of business, driving specialist fees down, while seeking to establish general practitioners as gatekeepers to keep patient flow down. But if anything, the opposite seems to be happening: specialists are stronger than ever. And that's good news for device companies whose marketing programs are geared to procedure-performing specialists.
You may also be interested in...
The US Senate’s vote to approve legislation underpinning the US-Mexico-Canada trade agreement has been welcomed by the country’s off-patent industry.
By merging to create Viatris, Mylan and Pfizer’s Upjohn unit intend to occupy a space between generics players and big pharma by offering a broad array of affordable products all around the world.
Progress is being made towards the implementation of the EU’s new patent system, but the UK’s insistence on severing all ties with the European Court could spell the end for its participation.